Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinshukang tablets in chronic stable angina
CTR20150431Phase 2Active
- Sponsor
- Tangshan Longshan Pharmaceutical
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Xinshukang in angina pectoris, coronary arteriosclerosis, sponsored by Tangshan Longshan Pharmaceutical. Started Jul 2015; status: active.
02
Drugs
Xinshukang
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on CTR20150431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150431.